Clinical trials
Emergence Delirium trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 12 |
| 2025 | 10 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Unknown status | 12 |
| Not yet recruiting | 11 |
| Recruiting | 10 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| RenJi Hospital | 5 |
| Beijing Tiantan Hospital | 4 |
| Henan Provincial People's Hospital | 4 |
| Peking University First Hospital | 3 |
| Affiliated Hospital of Nantong University | 2 |
| Fudan University | 2 |
| Peking University Third Hospital | 2 |
| Second Affiliated Hospital of Wenzhou Medical University | 2 |
| Yan Fuxia | 2 |
| Aerospace Center Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emergence Delirium | 66 |
| Delirium | 7 |
| Postoperative Cognitive Complications | 4 |
| Postoperative Pain | 4 |
| Hip Fractures | 3 |
| Postoperative Complications | 3 |
| Cerebral Small Vessel Diseases | 2 |
| Heart Defects, Congenital | 2 |
| Parasomnias | 2 |
| Psychomotor Agitation | 2 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.